Invitation to Telephone Conference Concerning Duni Interim Report 1 January – 31 March 2019

Telephone conference

The Interim report will be presented on Wednesday, 24 April at 09.00 AM CET at a telephone conference, which can also be followed via the web.

To participate in the telephone conference, please dial +46-8-566-426-51, Pin: 98038158#

To follow the presentation via the web, please visit this link:
http://event.on24.com/wcc/r/1973068-1/34DB88EF3D9325F6122341FAFE8AEACE?partnerref=rss-events 

Duni is a leading supplier of attractive and convenient products for table setting and take-away. The Duni brand is sold in more than 40 markets and enjoys a number one position in Central and Northern Europe. Duni has some 2,500 employees in 24 countries, headquarters in Malmö and production units in Sweden, Germany, Poland, New Zealand and Thailand. Duni is listed on NASDAQ Stockholm under the ticker name ‘DUNI’. ISIN-code is SE 0000616716.
Duni.com

This information is such that Duni AB (publ) is to publish in accordance with the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 16 April 2019 at 10.00 hrs CET.  

Additional information is provided by:
Mats Lindroth, CFO, +46-40-106200
e-mail mats.lindroth@duni.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/duni-ab/r/invitation-to-telephone-conference-concerning-duni-interim-report-1-january—31-march-2019,c2790217

The following files are available for download:

https://mb.cision.com/Main/295/2790217/1026950.pdf

Invitation to telephone conference concerning Duni Interim report 1 January – 31 March 2019

https://news.cision.com/duni-ab/i/fsr-hotel-20180626-duni-pr,c2611162

FSR-HOTEL-20180626 DUNI PR

 

BOX, Sweden, April 16, 2019 /PRNewswire/ — The interim report for Duni AB will be disclosed to the media for publication at 7.45 AM CET on Wednesday 24 April.

Amazing Discounts on Genuine Leather Products At Florence Leather Market

It is not news to anyone that Italian items are usually of the highest quality. If you are looking for chic, then you definitely have to go Italian. There's something unique about Italian products that makes you look classy and sophisticated when you step out with them. Maybe it's their unique design or maybe it's because they are made with the highest quality craftsmanship and artistry. Whatever reason you have for going for Italian products, you must check out this amazing Italian leather shop that goes by the name of Florence Leather Market.

Who they are

Well, florenceleathermarket is among the best online stores that sell genuine leather items like leather bags, belts, and wallets. They have a vast assortment of genuine leather goods that are handcrafted. There's nothing annoying like finding out that your bag or whatever item you have for that matter is made from fake leather. With this store, this is not the case since their products are indeed made from genuine leather. As aforementioned, they have a wide variety of fashion accessories that every girl or guy must have. From all sorts of leather bags to belts to even wallets. Their bags come in different colors and types like handbags, shoulder bags, backpacks, messenger bags, clutches, business bags and so many other types of bags. Everyone is catered for in this store. Their belts and wallets are for both men and women. No one is left out of owning these amazing products.

Pricing and website

When it comes to shopping, is there anything that beats excellent quality products obtained at affordable prices? I think not. Thank goodness for this awesome store that makes this very possible. The products at florenceleathermarket are not pricey. They come at very pocket-friendly prices. Their website FlorenceLeatherMarket.com is also pretty simple to navigate, making shopping with them very easy. If you visit the site, you will see that their images are high quality displaying their products in the best possible manner. The beautiful colors are very easy on the eyes.

Payment and discounts

Florence Leather Market have awesome discounts that should not be missed by anyone for whatever reason. If you visit their site, you will see that they have a 20% discount on wallets and a 10% discount on belts. To enjoy these discounts, all you have to do is visit their site and register for an account then you can shop away. Very simple. They have worldwide shipping by express courier and free shipping in Europe via DHL Economy. This applies for orders starting from 500 € or orders above 50 kgs. Their payment mode is through PayPal, Credit card, Countersign, and Bank transfer. If you haven't tried florenceleathermarket, you should. They are totally worth your while."

Making Profits, Saving Lives With Gene Therapy

NetworkNewsWire Editorial Coverage

  • Gene therapies tackle diseases by altering the genetic makeup of patients” cells.
  • Recent mergers and research developments make this a promising time to invest in the sector.
  • Gene therapy companies are developing treatments for everything from cancer and HIV to skin diseases.

Genprex Inc. (NASDAQ:GNPX) (GNPX Profile) is developing treatments to tackle lung cancer. Spark Therapeutics Inc. (NASDAQ: ONCE), which recently entered a merger agreement with the Roche Group, targets ailments such as retinal and neurodegenerative diseases. Dyadic International Inc (OTC:DYAI) is focused on finding uses for a fungal-based technology that could bring treatments to market faster. TrovaGene Inc. (NASDAQ:TROV) uses cell-level treatments to tackle cancer through inhibiting a specific enzyme. The technology developed by Novartis AG (NYSE:NVS) uses specific viruses to deliver treatment for a range of illnesses.

To view an infographic of this editorial, click here.

Saving Lives by Changing Genes

Genes are the fundamental building blocks of life, the lines of code that tell our bodies how to grow and behave. Since their discovery, our understanding of how we work has been transformed. But it”s only since the 1980s and the discovery of gene therapy that we”ve been able to work directly with genes toward the goal of saving lives.

Gene therapy involves the introduction of modified genetic material into a patient”s cells. Though gene therapy was first attempted on human cells in 1980, it took until 1989 for the first successful transfer of genes in a person. Early tests were dogged by challenges and controversy, but researchers persevered. More than 2,300 clinical trials of gene therapy were carried out between 1989 and 2016, providing a wealth of information about the workings of gene therapy, as well as the potential. Now, as the technology surges towards a wave of practical cures for patients, gene therapy has become a significant sector within the bioscience industry.

There”s never been a better time to buy into gene therapy.

Why Now?

Gene therapy isn”t exactly new. For years, companies such as Genprex Inc. (NASDAQ:GNPX) have been working on improvements to the technology and new ways to apply it in improving and saving lives. The highest profile work has been done in tackling cancer, an area in which Genprex specializes. The difficulty of treating cancer, combined with its origin in cell growth gone bad, makes gene therapy a natural fit for this area. But plenty of other uses have also been explored over the past three decades.

If gene therapy has been around for this long, why is now such an ideal time to invest?

One reason is that the industry has seen a series of mergers and acquisitions. Small-cap biotech company Spark Therapeutics, which specializes in gene therapy, was recently bought up by Roche for $4.8 billion, offering Spark investors a likely gain of 190 percent for this year. MeiraGTx Holdings, another small-cap gene therapy company, achieved an $80 million private placement, with Johnson & Johnson as its lead investor, pushing its shares up 67 percent so far this year. These and other moves show the interest of big medical companies in gene therapy.

This evidence of the faith of the markets has helped boost stock values for a range of gene therapy companies, with some seeing triple digit growth. But these companies don”t need to be the targets of mergers to benefit from this. A rising tide lifts all boats, and a shift in perspective that sees gene therapy as a mature and profitable endeavor increases confidence in companies such as Genprex, which are still working away in their own corners.

Another reason for the rising confidence in gene therapy companies — and a driver for these mergers — has been the successful development of new therapies. Recent research has seen developments in the use of gene therapy for a wide range of diseases, including such high profile and solidly funded areas as cancer and HIV.

This research has led to the development of new and exciting treatments. BioMarin is testing a gene therapy for hemophilia, which holds potential to more efficiently treat a difficult and expensive-to-tackle disease that can currently cost hundreds of thousands of dollars a year in treatment. Genprex is working on Oncoprex to tackle non-small cell lung cancer. News of promising results for a muscular dystrophy drug, alongside the purchase of a smaller gene therapy company, rallied shares in Sarepta Therapeutics and sent the stock up 34 percent in the first two months of 2019.

New therapies boost investor confidence and provide companies with more options, just like any tech innovation. And because of the special nature of their work, these companies do much more than that.

Saving Lives

Simply put, gene therapy can save lives. Like sustainable energy, gene therapy is one of those investments that makes the world a better place even as it makes the investor a profit. Money going into this sector is literally changing the world.

Gene therapy saves lives by altering the genetic makeup of a cell. Diseases can be caused by faulty copies of genes that don”t create the proteins they should within a cell. The insertion of better genes can restore function to the cell, building a healthier body from the most basic building blocks up. That”s why the work of companies such as Genprex can be so transformative.

Delivery systems for the genes are as important as the genes themselves. Carriers called vectors deliver the genetic material into the cells. These are often viruses, turning a life form that is hostile to humanity into one that benefits us. In the case of Genprex”s Oncoprex treatment, the genes are carried in an intravenously delivered nanovesicle, or a tiny compartment like those found in cells. The Oncoprex nanovesicle is small enough to cross barriers into the lungs, where it can deliver its genetic material to the cancer site.

Once in the lungs, the drug targets the negatively charged cancer cells. It”s taken into the cells, where it produces a protein that can restore failing functions caused by the cancer. The treatment interrupts the pathways that cause cancer cells to reproduce and rebuilds the pathways that lead these cells to die. It also blocks mechanisms that cause resistance to anti-cancer drugs.

This uses one of two forms of gene therapy: gene replacement therapy.  Currently, gene replacement therapies are the only ones approved by the FDA. The alternative, gene editing, has been the subject of various clinical trials but has not yet led to an approved treatment. For now, gene replacement therapy, or tackling unhealthy cells through the addition of healthy genes, is the proven way forward to gene therapy, and the approach appears to be serving Genprex well.

The Gene Therapy Industry

Advancements in gene therapy over the past thirty years have led to a range of companies specializing in this area.

Spark Therapeutics Inc. (NASDAQ: ONCE) is a commercial gene therapy company that specializes in treatment for inherited retinal diseases, neurodegenerative diseases and diseases that can be treated through the liver. The company tackles rare inherited diseases at their root by treating mutated genes, augmenting, suppressing or replacing those genes, depending upon how they negatively affect the body. The company”s expertise and technology has drawn the attention of the Roche Group, and the two entered into a merger agreement in February. Spark will continue to operate as an independent company within the Roche Group but with the benefit of that group”s substantial financial backing.

Based in Florida and the Netherlands, Dyadic International Inc. (OTCQX:DYAI) is a biotech company that focuses on finding applications for a fungus-based technology that the company has nicknamed C1. This can be used to increase the speed and efficiency with which drugs are created. The technology is used in a wide range of treatments, including vaccines, antibodies and enzyme therapies. The company placed at No. 36 on the 2019 OTCQX Best 50 list, a list of the top 50 companies listed on the OTCQX market.

TrovaGene Inc. (NASDAQ:TROV) is an oncology therapeutics company developing drugs that will affect cell division to tackle the growth of cancers. The company”s treatments work by using a Polo-like Kinase 1 (PLK1) Inhibitor, which reduces the overexpression of an enzyme common in cancer cells. By changing cell division and the repair of damage within the cell, these treatments are designed to save the lives of cancer patients. TrovaGene currently has two ongoing clinical trials and will be reporting on its progress at the American Association for Cancer Research Annual Meeting in April.

Novartis AG (NYSE:NVS) is working on gene therapies using adeno-associated viruses (AAVs) to deliver the treatment. The company uses innovative science and technology to address some of society”s most challenging healthcare issues. Recent research by Novartis has shown successful results in treating patients with the skin condition psoriasis, with nine out of ten patients achieving clear or almost-clear skin during the first 16 weeks of treatment. The company is also working on issues such as cardiovascular disease.

Gene therapy is opening up new treatments for a huge range of diseases and appears to hold out promise for a healthier world.

For more information about Genprex, please visit Genprex Inc. (NASDAQ:GNPX).

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today”s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with NNW or any company mentioned herein. The commentary, views and opinions expressed in this release by NNW are solely those of NNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW and FNM for any investment decisions by their readers or subscribers. NNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer”s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer”s securities, including, but not limited to, the complete loss of your investment.

NNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains ‘forward-looking statements’ within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. ‘Forward-looking statements’ describe future expectations, plans, results, or strategies and are generally preceded by words such as ‘may’, ‘future’, ‘plan’ or ‘planned’, ‘will’ or ‘should’, ‘expected,’ ‘anticipates’, ‘draft’, ‘eventually’ or ‘projected’. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company”s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and NNW and FNM undertake no obligation to update such statements.

NetworkNewsWire (NNW) is affiliated with the Investor Brand Network (IBN).

About IBN

Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) www.InvestorBrandNetwork.com

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com 
+1-212-418-1217 Office
Editor@NetworkNewsWire.com   

Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611

 

NEW YORK, March 12, 2019 /PRNewswire/ — After thirty years of development, gene therapy is seeing a surge of progress and profitability.

[[[tasteofexc

Digital Signage Market Worth $29.6 Billion by 2024 – Exclusive Report by MarketsandMarkets™

Ask for PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=513

Growing smart signage applications, increasing retail space worldwide, rising demand for context-aware signage, and increasing transition of traditional stores to smart stores in the retail vertical expected to offer high growth opportunities in the near future.

‘Hardware offering to dominate digital signage market (in terms of share) during forecast period’

Hardware offering currently accounts for the largest share of the digital signage market, and this trend is expected to continue during the forecast period. Displays to dominate the entire digital signage hardware market during the forecast period owing to increasing usage of digital signage systems for both indoor and outdoor applications in verticals such as commercial, infrastructural, and institutional. Rising demand for high picture quality, attractive design, and high specification-based displays are driving the growth of the digital signage hardware market. Newer technologies such as fine-pixel LED and OLED are expected to drive the growth of the digital signage market for hardware devices during the forecast period.

Browse in-depth TOC on ‘Digital Signage Market

63 – Tables

56 – Figures

186 – Pages

‘Digital signage market for outdoor application to grow at highest CAGR from 2019 to 2024’

The outdoor digital signage are widely used in transportation and public places, sports, and hospitality verticals. The penetration of outdoor advertising is expected to be high in transportation and public places during the forecast period. Digital signage typically represents large advertisements in high-traffic areas for pedestrians and drivers. This attracts a lot of customers as advertisements are largely visible at express highways and high-density consumer exposure areas. Constantly changing or blinking text creates an impact on customers and enables a wide exposure for the targeted audience, thereby driving the market for outdoor digital signage.

‘APAC to grow at highest CAGR in digital signage market during forecast period’

The market in APAC is expected to exhibit the highest growth rate in the digital signage market because of its awareness of the benefits of digital signage solutions in retail, transport, banking, and entertainment. APAC is witnessing dynamic changes in the adoption of new technologies and advancements in retail and infrastructural verticals. China, South Korea, and Japan are the early adopters of digital signage products in this region. However, countries such as India, Australia, Singapore, Thailand, and Malaysia are expected to witness the highest growth in the digital signage market.

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=513

Key players in the market include Samsung Electronics (South Korea), NEC Corp. (Japan), LG Electronics (South Korea), Sharp (Foxconn) (Japan), Leyard Optoelectronic (Planar) (China), Sony (Japan), AU Optronics (Taiwan), BARCO (Belgium), Panasonic (Japan), Goodview Electronics (China), Scala (US),  E Ink Holdings (Taiwan), Omnivex Corporation (Canada), Deepsky Corporation (Hong Kong), Delta Electronics (Taiwan), Exceptional 3D (US), Daktronics (US), Christie Digital Systems (US), Intuiface (France), and BenQ (Taiwan).

Please Explore Relevant Reports:

Display Market by Product (Smartphone, Wearables, Television, Automotive, Signage), Technology (LCD, OLED (Flexible, Foldable, Rigid), Direct-View LED, Micro-LED), Panel Size (Micro, Small & Medium, Large), Industry, and Geography – Global Forecast to 2024 

Large Format Display Market by Offering, Display Type (Video Wall & Standalone), Technology (LED-Backlit LCD, Direct-View LED, OLED, E-Paper), Size, Brightness Level, Application (Indoor & Outdoor), Vertical, and Region – Global Forecast to 2023 

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies” revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the ‘Growth Engagement Model – GEM’. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write ‘Attack, avoid and defend’ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets”s flagship competitive intelligence and market research platform, ‘Knowledge Store’ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/digital-signage-market.asp 

Visit Our Web Site: https://www.marketsandmarkets.com

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg  

CHICAGO, March 7, 2019 /PRNewswire/ — According to the new market research report on the ‘Digital Signage Market by Offering (Hardware (Displays, Media Players, Projectors), Software, Services), Product, Application, Vertical (Retail, Transportation & Public Places, Sports & Entertainment, Education), and Geography – Global Forecast to 2024’, published by MarketsandMarkets™, the Digital Signage Market is expected to grow from USD 20.8 billion in 2019 to USD 29.6 billion by 2024, at a CAGR of 7.3%. Growing technological advancements in display products, increasing adoption of digital signage products in commercial vertical, rising demand for 4K & 8K displays, and increasing infrastructural developments in emerging countries are the major driving factors for the market”s growth during the forecast period.

[ [ [

Global Animal Model Market to Receive Impressive Traction From Vaccine Testing, Reports Fact.MR

According to this Fact.MR study, the animal model market is expected to register an impressive growth rate at 6.0% CAGR during the forecast period between 2017 and 2026. It has been analyzed that, the healthcare sector is the supreme marketplace that harnesses animal models, and is primarily driven due to the rising need for vaccine testing.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1590

North America Endures the Most Promising Market for Animal Models

Looking at the geographical outlook, North America is likely to showcase the highest demand for animal models during the stated forecast period. The study reveals that hefty investments along with relevant policy reformations issued by the government are expected to stimulate funding schemes that are concerned with animal model research. Furthermore, several leading players are making sizeable investments to make this region a lucrative arena for the animal model market.

Based on revenue, academic & research institutions are expected to contribute the maximum share in the global animal model market. Interestingly, the hopes of massive leaps across research and development activities are pushing this segment to witness encouraging breakthroughs in the coming years.

Browse Full Report on Animal Model Market with in-depth TOC- https://www.factmr.com/report/1590/animal-model-market

Vaccine Testing to Impose Surging Need for Animal Models

It is important to know that upgradation with human vaccines depend on animal models to a great extent. There are certain regulatory authorities which have made it mandatory for novel vaccine companies to fulfill preclinical tests in animal models before they are proven authorized for clinical experiments on human subjects. With an enhanced demand for vaccine testing and development, the need for animal model has swelled the target market”s growth rate to a souring level.

Competitive Scenario

This Fact.MR study carefully analyzes the major players functioning in the global market for animal model. Each of the companies mentioned in the report have shown remarkable contribution to the overall market growth. Genoway SA, Crown Bioscience, Inc., Eurofins Scientific SE, Transposagen Biopharmaceuticals, Inc and Envigo CRS SA, are the leading market players which are assessed based on their acquisitions, takeovers and mergers. Moreover, these players are also investigated in terms of fresh product fortification strategies with an aim to strengthen their foothold across the worldwide market.

Ask Our Industry Expert for more details on report- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1590

Overall, this research study focusing on the animal model market incorporates all-inclusive secondary sources, pertinent databases and directories, with a purpose to identify and collect information that are useful for the concerned market. In addition, primary sources include industry personnel connected to core industries, manufacturers, prominent suppliers, distributors etc., associated to value chain of the industry.

Popular Healthcare Market Reports from Fact.MR

Natural Cold, Cough, and Sore Throat Remedies MarketGrowing instances of respiratory diseases due to modern lifestyle choices, and exposure to growing concentration of pollutants in the environment, is expected to underpin growth of the natural cold, cough and sore throat remedies market.

Dyslipidemia Therapeutics MarketCombination therapies for dyslipidemia have gained a marked significance in the recent past, deemed as an efficient solution to offset concerns regarding varied effectiveness of statins with respect to affected patients.

Cancer Profiling MarketAccording to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for nearly 9.6 million deaths in 2018 worldwide. While major strides are being made to prevent cancer development, the medical community still need to address the estimates of new cancer cases projected in coming years.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that”s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

ROCKVILLE, Maryland, Feb. 27, 2019 /PRNewswire/ –Over the past few years, rapid developments across the healthcare sector to curb the prevalence of chronic diseases has motivated the increasing need for research activities. The use of animal models for biomedical research has experienced a significant rise since it has proven helpful for the development of new treatment techniques to tackle a variety of chronic diseases. To study the overall market presence for animal models, Fact.MR has published a new research report titled ‘Animal Model Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026‘, which has been included to its broad online database. The purpose of this assessment is to examine the diverse trends prevailing across the animal model market, together with the reviewing of primary facets such as market size, revenue share, value chain and a lot more.

[

Gfinity to Host Call of Duty® World League: London

LONDON, Feb. 4, 2019 /PRNewswire/ — Gfinity, a world-leading esports solutions provider, today announced it will host the third open event of the 2019 Call of Duty® World League season, CWL London, at the 7,500 capacity Copper Box Arena in London running 3rd-5th May 2019. The event, featuring Call of Duty®: Black Ops 4 from developer Treyarch Studios, feeds into the Call of Duty® World League Championship which takes place in August 2019. CWL London features 16 of the top CWL professional teams competing for prizing as well as an amateur tournament with its own dedicated prize pool which will feature up to 200 teams.

The Call of Duty World League, presented by PlayStation®4, has transitioned into a new five-versus-five format with zero region restrictions for LAN tournaments, giving the best players and teams from all around the world the opportunity to compete in every tournament. The season launched December 2018 in Las Vegas with OpTic Gaming coming out on top. The event saw opening weekend records as highest viewed CWL open event in history, number of competitors and overall social engagement, according to Activision internal data.

Garry Cook, Executive Chairman, Gfinity: ‘In May, London will become the focus of the gaming world. Gfinity is going to put on a show and deliver an experience that will excite the global Call of Duty esports community. We know the players and fans and the passion they will bring to the Copper Box Arena. London is in for a treat.’

CWL London marks Gfinity”s first major Call of Duty event since 2016 and a return to the Copper Box Arena for the first time since the Last Chance Qualifier event during the 2017 Call of Duty World League season.

For all general information including team registration and ticket news, go to cwl.gfinityesports.com  

More information about Gfinity is available at www.gfinityplc.com

 

 

CWL London to be staged in Iconic Copper Box Arena in May 2019

Bitecnology.com – Mixing Tank

We came up with the idea of merging BI tecnlogy with I.mec after careful consultation with our clients from Italy and other parts of the world. I.mec has been a go-to for a wide range of pumps, agitators, and tanks since the late 80s. It produces products for the following sectors; ceramic, food, industrial, pharmaceutical, certifications, and recycling.

The Company

Our certification

Our Products and Fields of Application

Our Mixing Tanks

Conclusion

The Company

The mission of our company is to completely satisfy everyone who turns to us. We pursue that goal in every service that we provide. BI technology and I.mec tries to be as reliable as possible in different scenes including iron removal and screening.

Our Products and Fields of Application

We make products for use in various sectors. They include the following.

• Vibrating sieves

• Mastelli

• Metallic cloths

• Agitators

• Mill unloading groups

• Deferrizers and filters

• Pumps

• Melter Groups

Our Certification

We have certification to confirm that our products and services are legal and safe for use. The following are some of our certifications. In the EU, certification may either be compulsory or voluntary depending on the product in question. Companies that choose to get certification even when it is not a requirement help their clients to trust them. Certification is equal to assurance that a product or service is safe and reliable. Bitecnology performs well and meets the industry quality standards. Some of the company’s certifications include; Ex Atex and TUV InterCert SAAR Certificate.

Mixing Tank

If you are looking for an industrial tank, we may provide you with a solution. You can get a quote for your Bitecnology.com – Mixing Tank by speaking to one of our agents or filling out a form on our site. Contact us on 39 0522 927009 or 39 0522 517492. When buying your tank from us, it is important to consider the needs of your industry. The specifications should suit your needs. Ensure that the design gives you a wide application with little crush. Ensure that it is stable and the loading rate meets your expectations.

Our agents will provide you with truthful information about the product to ensure that you make an informed choice. Our tanks are designed to last long and avoid leakage. If you are unsure of the right tank for your needs, we are happy to give you advice. Our quotes are competitive, and we do not impose any hidden charges.

Artificial Intelligence Helps Antwerp University Hospital Radiologists Save Lives

TEL AVIV, Israel and ANTWERP, Belgium, Jan. 21, 2019 /PRNewswire/ — Aidoc, the leading provider of AI solutions for radiologists announced that Antwerp University Hospital has purchased Aidoc”s neuro solution. Aidoc identifies time-sensitive and life-threatening conditions in CT scans, flagging them to ensure that the images are seen immediately by a radiologist. This results in faster diagnoses and higher quality patient care. Antwerp University Hospital was among the first institutions in Europe to incorporate Aidoc”s cutting-edge technology.

Earlier last year, the university hospital was the first facility in Europe to incorporate Aidoc”s solution into their clinical workflow in order to better detect two life-threatening conditions: cervical spine (C-spine) fractures and intracranial hyperdensities (ICH).

Radiology is one of Antwerp University Hospital”s focal points, performing 160,000 procedures per year, offering high-quality patient care, and embracing ground-breaking research. The hospital prides itself in its forward-thinking radiology department, which is constantly taking steps to increase efficiency through the incorporation of innovative technologies. The ability of the hospital to apply Aidoc”s solution into their already existing GE PACS without making any changes to their workflow is revolutionary for both the patients and the radiologists.

‘Aidoc helps us to make important imaging decisions,’ said Prof. Paul Parizel, Chairman of Imaging at the University of Antwerp. ‘AI is becoming increasingly important in all elements of radiology. Historically, neuroradiology has always been the starting point of innovation. Aidoc has wisely started by detecting the most critical cases, speeding up diagnosis in areas where time really matters.’

‘Our solution works alongside radiologists, providing them with the ability to make precise, timely decisions for optimal patient care,’ said Aidoc”s CEO Elad Walach. ‘Aidoc isn”t meant to replace the radiologists, rather it is used to enhance their capabilities, drastically improving patient care. The Antwerp University Hospital is an amazing partner that recognized that to advance in the medical field they must incorporate forward-thinking tools into their workflow, optimizing the quality of the care they provide their patients, and ultimately saving lives.’

The adoption by Antwerp University Hospital is expected to be quickly followed by other top hospitals in the region.

Media contact

Ariella Shoham
VP Marketing
Aidoc
ariella@aidoc.com

 

The Antwerp University Hospital radiology department uses Aidoc”s innovative AI solution to improve the quality of patient treatment and increase department efficiency

[[[tasteofexc

UK Video Games Industry Set For Year of Growth

TIGA, the network for game developers and digital publishers and the trade association representing the video games industry, released a Business Opinion Survey today which shows that the industry is set for a year of growth. 77 per cent of respondents plan to grow their organisation”s workforce over the course of 2019. 62 per cent of respondents believe that the economic and business environment in the UK is favourable to the video games industry. Access to finance, skills issues and marketing remain the key obstacles to UK games businesses.

TIGA”s Business Opinion Survey 2018-19 was carried out at the end of 2018. The survey is based upon a representative sample of 60 games businesses including small, medium and large firms, developing games across mobile/tablet, VR, PC and console. Percentages are rounded throughout this report and so do not always add up to 100 per cent.

TIGA”s Business Opinion Survey 2018-19 includes the following key findings:

  • Employment: 77 per cent of respondents plan to grow their organisation”s workforce over the next year (compared to 68 per cent of respondents in last year”s survey). 23 per cent expected to keep their organisation”s workforce at current levels and 2 per cent thought that their organisation”s workforce would diminish a little.

  • Economic environment: 62 per cent of respondents to the TIGA survey believe that the economic and business environment in the UK is favourable to the video games industry (compared to 70 per cent a year ago). 28 per cent consider that the environment is neither favourable nor unfavourable to the sector, 5 per cent feel that it is unfavourable and 7 per cent do not know.

  • Investment: 52 per cent of respondents to the TIGA survey said that the outlook for investment in their business (for example, in R&D, training, new games development, etc) was more optimistic than compared to 12 months ago. 35 per cent said that the outlook was unchanged. 12 per cent said the outlook for investment was less optimistic.

  • Performance: 77 per cent of respondents reported that their company was performing either ”very well” or ”well” (compared to 62 per cent twelve months” ago). 18 per cent said that their company was performing ”neither well nor badly”. Just 5 per cent reported that their company was performing ”badly” or ”very badly”.

  • Prospects: 57 per cent of respondents said that they were more optimistic about their company”s prospects compared to 12 months ago (up from 46 per cent a year ago). 25 per cent reported that they were neither more nor less optimistic, while 15 per cent said that they were less optimistic about their organisation”s prospects.4 per cent did not know.

  • Obstacles to success: 33 per cent of the respondents to the TIGA survey said that the principal obstacle holding back their businesses was limited access to finance. 30 per cent identified skills shortages and skills gaps. A further 25 per cent cited discoverability as the biggest obstacle. 7 per cent referred to difficulties securing new projects or publishing deals. Others referred to: a lack of space for expansion; a lack of support for games services companies; the challenge of Brexit; and the need to make the UK”s Video Games Tax Relief more internationally competitive.

Commenting on the survey findings, Dr Richard Wilson OBE, TIGA CEO, said:

‘The UK video games development and digital publishing sector is set for another year of expansion. 77 per cent of respondents to our survey are planning to increase employment over the coming year. 62 per cent of games businesses in our survey believe that the economic and business environment in the UK is favourable to the video games industry (although this is a lower proportion than a year ago). Video Games Tax Relief, which TIGA was instrumental in achieving, is fuelling growth in the sector. Games Tax Relief effectively reduces the cost and risk of games development and incentivises investment and job creation in the games industry.

‘The Government can capitalise on our industry”s strong position by improving our access to finance and to highly skilled people. On finance, the Government should consider introducing TIGA”s proposal for a Games Investment Fund (GIF). The GIF would make grants or loans of between £75,000 and £500,000 available to games businesses on a matched funding basis.[1]

‘The Government”s emphasis on boosting STEM skills is sensible. However, our industry needs to have access to highly-skilled employees from the EU, EEA and beyond. Currently, EU workers make up 15 per cent of the UK games industry, while 5 per cent come from countries outside the EU. UK games businesses will continue to invest in training, while TIGA will continue to accredit university games courses to encourage a good supply of high quality graduates.[2] Yet if we are to achieve our potential, then the UK video games industry will need to continue to recruit global talent.’

Jason Kingsley OBE, TIGA Chairman, and CEO and Creative Director at Rebellion, said:

‘2019 shows all the signs of being another great year for our industry. We should see more start-ups, expansion and innovation within the sector. We can strengthen our industry still further by improving access to finance and skills and ensuring that the UK has a migration policy post-Brexit that is favourable to growth. TIGA looks forward to continuing its work with the Government in 2019 to ensure our industry achieves its potential.’

About TIGA

TIGA is the network for games developers and digital publishers and the trade association representing the video games industry. Our core purpose is to strengthen the games development and digital publishing sector. We achieve this by campaigning for the industry in the corridors of power, championing the industry in the media and helping our members commercially.

TIGA is intent on building an enduring organisation which continually improves; a business that will make a significant impact on the games industry and so benefit our membership and the wider economy. Since 2010, TIGA has won 28 business awards, an achievement which reflects TIGA”s drive for improvement and to meet best practice.

Video Games Tax Relief has been available to UK games companies since April 2014 and applications have grown each year. Since the introduction of Video Games Tax Relief, £230 million has been paid out in response to 770 claims. A total of 480 video games productions have claimed Video Games Tax Relief, accounting for over £1 billion of UK expenditure (HM Revenue and Customs, 19 July 2018).

For more information visit: www.tiga.org

Get in touch:

Tel: +44-845-468-2330
Email: info@tiga.org

Web: www.tiga.org
Twitter: www.twitter.com/tigamovement
Facebook: www.facebook.com/TIGAMovement
LinkedIn: http://www.linkedin.com/company/tiga

 

[1]  Further information available here: http://tiga.org/news/tiga-calls-for-the-launch-of-a-video-games-investment-fund

[2] Further information available here: http://tiga.org/education/tiga-university-accreditation

LONDON, January 7, 2019 /PRNewswire/ —

Powermat Unveils New Flexible Wireless Charging Experience With AgileInductive(TM) Technology

First wireless charging technology that can be placed on or below the table, bringing flexible and easy-to-use technology to more customers around the globe

Powermat is excited to offer the reference design of AgileInductive™ technology, a flexible wireless charging platform that will make it easier than ever for businesses and home users to enjoy a seamless inductive charging experience with no drilling or screws required.

     (Logo: https://mma.prnewswire.com/media/624584/Powermat_Logo.jpg )

     (Photo: https://mma.prnewswire.com/media/799192/Powermat_Wireless.jpg )

Placing the transmitter on the table, will have it function as a regular wireless charging pad. Placing the transmitter below the table and a sticker on top enables through-surface magnetic inductive charging. The transmitter is not permanent on the table and can be moved when needed. The end-result is a sleek and clean solution — no cords, unsightly hardware or drill holes.

AgileInductive technology brings all the benefits of Powermat”s technology including fast charging (up to 15W) and compatibility with all wireless charging standards, including Qi, Apple 7.5W, Samsung Fast Charge and other fast charging capabilities. To support the unique through-surface range (for surfaces up to 1.2′ thick), technology comes with built-in protections such as voltage, current & thermal protections, and advanced FOD calibration and tracking.

‘As the leader and pioneer in wireless charging technology, Powermat is fiercely working on developing new wireless charging technologies, staying ahead-of-the-curve to support new use cases,’ said Elad Dubzinski, Powermat CEO. ‘Powermat has always focused on making wireless charging available to everyone. With AgileInductive, we”re bringing advanced through-surface inductive technology, while creating a simple and user-friendly experience.’

For the hospitality market, Powermat is also proud to announce the new generation of the surface integrated wireless charger, Charging Spot 3.1 Rev B. Based on the durable design we know & love, Charging Spot 3.1 Rev B is Qi certified and includes fast charging (up to 15W and extendable up to 40W for supported receivers), universal support for all wireless charging standards, BLE based connectivity and over-the-air updates providing future upgrades to support new functionalities.

To learn more about Powermat”s AgileInductive technology, please visit https://www.powermat.com/technology/agileinductive.

About Powermat   

Powermat is the wireless charging pioneer and leader, provider of the largest wireless charging network in the world, and the forefront of inductive wireless charging technology development. Powermat owns the Intellectual Property of essential elements in induction wireless charging, creating future-proof technology. OEM providers of mobile phones, automotive, computing and more, can rely on Powermat for the most advanced wireless charging technology. Supported by our market leader partners such as Starbucks, Samsung, General Motors & Flex, we can all live life at 100%. For more information, please visit http://www.powermat.com.

Press Contact
Vanessa Ferguson
FH High Road
+1-613-688-6678
vanessa.ferguson@FHhighroad.com 

TEL AVIV, Israel, December 18, 2018 /PRNewswire/ —

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi